Jefferson, Robert E. http://orcid.org/0000-0002-8641-8736
Oggier, Aurélien
Füglistaler, Andreas http://orcid.org/0000-0001-6448-5981
Camviel, Nicolas
Hijazi, Mahdi http://orcid.org/0000-0003-3060-3147
Villarreal, Ana Rico
Arber, Caroline http://orcid.org/0000-0001-6440-9970
Barth, Patrick http://orcid.org/0000-0002-0744-6844
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_182263, 310030_208179)
Article History
Received: 27 September 2022
Accepted: 4 May 2023
First Online: 19 May 2023
Competing interests
: P.B. holds patents and provisional patent applications in the field of engineered T cell therapies and protein design. C.A. receives royalties from Immatics and holds patents and provisional patent applications in the field of engineered T cell therapies. All other authors declare no competing interests.